Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicityYasmina Mozo, Beatriz Ruz-Caracuel, David Bueno et al.|Pediatric Hematology and Oncology|2021Cited by 28
Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in ChildrenCristina Díaz de Heredia, Antonia Rodríguez Villa, María Luz Uria Oficialdegui et al.|Bone Marrow Transplantation|2020Cited by 16
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)María Isabel Benítez‐Carabante, Cristina Díaz de Heredia, David Bueno et al.|Transplantation and Cellular Therapy|2024Cited by 13
Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in childrenMaría Luz Uria Oficialdegui, Cristina Díaz de Heredia, Laura Alonso et al.|Pediatric Transplantation|2021Cited by 10
Matched sibling donor stem cell transplantation for sickle cell disease: Results from the Spanish group for bone marrow transplantation in childrenMaría Isabel Benítez‐Carabante, Cristina Beléndez, Marta González‐Vicent et al.|European Journal Of Haematology|2020Cited by 10